Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;38(2):195-211.
doi: 10.1016/j.ccc.2021.11.013.

Subtypes and Mimics of Sepsis

Affiliations
Review

Subtypes and Mimics of Sepsis

John A Kellum et al. Crit Care Clin. 2022 Apr.

Abstract

Sepsis is a heterogenous and imprecise syndrome that includes multiple phenotypes, some of which are amenable to specific therapies. Developing new therapies for sepsis will require focusing on subsets of patients. Key to improving care is evaluating patients for sepsis mimics and treatable diseases whose manifestations lead to a clinical classification of sepsis. Because sepsis is common, it is easy to overlook unusual causes of organ failure and succumb to confirmation bias about the nature of an illness. Careful attention to medical and family histories, focused diagnostic testing, and subspecialty input can help identify potentially treatable diseases masquerading as typical sepsis.

Keywords: Atypical hemolytic uremic syndrome; Blood purification; Endotoxemia; Endotoxin; Macrophage activation syndrome; Polymyxin B.

PubMed Disclaimer

Conflict of interest statement

Disclosure J.A. Kellum discloses grant support and consulting fees from Astute Medical/BioMerieux and Baxter and currently is a full-time employee of Spectral Medical. H. Gómez discloses grant support and consulting fees from BioMerieux. All other authors declare no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
The spectrum of organ failure seen in sepsis.
Fig. 2.
Fig. 2.
Pathogenesis of MAS. IFNg, interferon gamma; Th-1, type 1 helper T cells.

References

    1. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–10. - PMC - PubMed
    1. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) study. Arch Intern Med 2007;167(15):1655–63. - PMC - PubMed
    1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369(9):840–51. - PubMed
    1. Brinkworth JF, Valizadegan N. Sepsis and the evolution of human increased sensitivity to lipopolysaccharide. Evol Anthropol 2021;30(2):141–57. - PubMed
    1. Wassenaar TM, Zimmermann K. Lipopolysaccharides in food, food supplements, and probiotics: should we be worried? Eur J Microbiol Immunol (Bp) 2018; 8(3):63–9. - PMC - PubMed